Skip to main content
. 2021 Jul 27;13(14):18993–19012. doi: 10.18632/aging.203348

Figure 5.

Figure 5

Targets of GF against AD in control and AD groups of GEO dataset. (AC) Entorhinal cortex, n = 39 in each group. (D, E) Hippocampus, n = 66 in healthy control, n = 74 in the AD patients. (FL) Temporal cortex, n = 39 in healthy control, n = 52 in the AD patients. Values are presented as mean ± standard errors mean (SEM).